Cargando…
Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
The Radiation Therapy Oncology Group (RTOG) 9310 protocol clinical trial established high-dose methotrexate (HDMTX) as the standard for primary central nervous system lymphoma (PCNSL). We aimed to investigate the RTOG 9310 protocol’s PCNSL outcomes by examining progression-free survival (PFS) and ov...
Autores principales: | Kim, Jinuk, Kim, Tae Gyu, Lee, Hyoun Wook, Kim, Seok Hyun, Park, Ji Eun, Lee, Moonok, Kim, Young Zoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628744/ https://www.ncbi.nlm.nih.gov/pubmed/34898570 http://dx.doi.org/10.3390/curroncol28060393 |
Ejemplares similares
-
A Case of Primary Central Nervous System Lymphoma Located at Brain Stem in a Child
por: Kim, Jinho, et al.
Publicado: (2016) -
Factors Influencing the Response to High Dose Methotrexate-based Vincristine and Procarbazine Combination Chemotherapy for Primary Central Nervous System Lymphoma
por: Sung, Kang Hyun, et al.
Publicado: (2011) -
Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma
por: Kim, Hoon Gi, et al.
Publicado: (2022) -
Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma
por: Kim, Jeong Eun, et al.
Publicado: (2012) -
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
por: Yoon, Sang Eun, et al.
Publicado: (2022)